Comments on Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018(English version)

作     者：Weiping Liu Jun Zhu 

作者机构：Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Lymphoma Peking University Cancer Hospital & Institute 

出 版 物：《Chinese Journal of Cancer Research》 (中国癌症研究（英文版）)

年 卷 期：2019年第31卷第5期

页      面：738-739页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：diagnosis neoplasms treatment 

摘      要：Lymphoid and myeloid neoplasms are common malignant tumors in China,which threaten people’s health(1).To improve the diagnosis and treatment of lymphoma,the National Health Commission of the People’s Republic of China revised Chinese guidelines for diagnosis and treatment of malignant lymphoma in 2018(2).The new guidelines are based on the Classification of Tumours of Haematopoietic and Lymphoid Tissues revised by the World Health Organization in *** new edition provided principles of accurate pathological diagnosis of lymphoma on the basis of various scales including histomorphology,immunohistochemistry,fluorescent immunohybridization and genetics.